Taribavirin Showing Lower Anemia Rates than Ribavirin
When combined with pegylated interferon for Hepatitis C treatment, taribavirin may be a better option than ribavirin. Compared to ribavirin, preliminary results of a Phase IIb trial show that taribavirin is similar in viral load reduction yet superior with fewer incidences of treatment related anemia.
Continue reading »